Goldman Jonathan
Insider CIK 2013869 · AVTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AVTX Avalo Therapeutics, Inc. | M Exercise deriv | 2026-03-28 | 2026-03-31 | 3,166 | — | $0 | 3,167 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise | 2026-03-28 | 2026-03-31 | 3,166 | — | $0 | 3,166 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise deriv | 2025-11-14 | 2025-11-17 | 8,200 | — | $0 | 16,400 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | S Sale | 2025-11-14 | 2025-11-17 | 3,167 | $14.30 | $45.3K | 0 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise | 2025-11-14 | 2025-11-17 | 8,200 | $9.88 | $81.0K | 8,200 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | S Sale | 2025-11-14 | 2025-11-17 | 8,200 | $14.35 | $117.7K | 0 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2025-06-17 | 2025-06-18 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise deriv | 2025-03-28 | 2025-04-01 | 3,167 | — | $0 | 6,333 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | M Exercise | 2025-03-28 | 2025-04-01 | 3,167 | — | $0 | 3,167 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2024-08-13 | 2024-08-14 | 9,500 | — | $0 | 9,500 | SEC↗ |
| AVTX Avalo Therapeutics, Inc. | A Award deriv | 2024-08-13 | 2024-08-14 | 24,600 | — | $0 | 24,600 | SEC↗ |